NCT04383587View on ClinicalTrials.gov

Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

July 31, 2020

Conditions
SARS-CoV 2COVID-19
Interventions
OTHER

Serologic testing

COVID19 IgG antibody testing to be performed

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04383587 - Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers | Biotech Hunter | Biotech Hunter